WEEKLY EQUTY REPORT BY EPIC RESEARCH-26 NOVEMBER 2012
-
Upload
epic-research-private-limited -
Category
Economy & Finance
-
view
232 -
download
0
description
Transcript of WEEKLY EQUTY REPORT BY EPIC RESEARCH-26 NOVEMBER 2012
WEEKLY NEWS
Hindustan Copper OFS discovered price at Rs
157/share
The offer for sale (OFS) of Hindustan Copper's 3.7 crore
shares got over-subscribed by 18 lakh shares today.
The company received total bids received for 3.89 crore
shares. The discovered price of the OFS is Rs 157 per
share against offer price of Rs 155 per share. The
government is likely to raise nearly Rs 600 crore via
stake sale. Commenting on the Hindustan Copper OFS,
Finance Minister P Chidambaram said, the issue shows
resumption of divestment process. He hopes the
government will be able to raise Rs 30,000 crore from
PSU divestment in FY13.
Siemens India: High costs, employee costs
weighed heavy on financial performance
High costs, especially those on account of raw materials
and employee costs weighed heavy on the financial
performance of Siemens India for the financial year
2011-12. The company's EBITDA (earnings before
interest, tax and depreciation) margins declined by more
than 400 basis points for the year to less than 7% as
compared to the previous year despite registering 7.5%
growth in revenues during the year. The company's
Managing Director, Dr Armin Bruck, said, "The results
reflect the slowdown in the Indian economy and the
same are below our own expectations. Higher project
costs and un-booked profits due to customers delaying
off-take has impacted the overall profitability.
http://www.epicresearch.co 09752199966 09993959693
WEEKLY EQUITY NEWSLETTER 26TH NOVEMBER 2012
MARKET UPDATE:-
Nifty down by 1.15 pts
and settle at 5626.60
Bank Nifty down by 32.55 pts at 11475.80
NIFTY WEEKLY PIVOTS
http://www.epicresearch.co 09752199966
MARKET ANALYSIS THE MARKET ROSE LAST WEEK AS INVESTORS BOUGHT SHARES AHEAD OF THE WINTER SESSION OF THE
PARLIAMENT THAT BEGAN ON THURSDAY, 22 NOVEMBER 2012. THE MARKET SENTIMENT WAS ALSO
BOOSTED BY DATA SHOWING THAT FOREIGN INSTITUTIONAL INVESTORS (FIIS) REMAINED NET BUYERS OF
INDIAN STOCKS IN NOVEMBER 2012. THE BSE SENSEX ROSE 197.20 POINTS OR 1.08% TO 18,506.57 IN THE WEEK ENDED FRIDAY, 23
NOVEMBER 2012. THE 50-UNIT S&P CNX NIFTY ROSE 52.55 POINTS OR 0.94% TO SETTLE AT 5,626.60. THE 50-UNIT S&P CNX NIFTY ROSE 52.55 POINTS OR 0.94% TO SETTLE AT 5,626.60. AMONG THE 30-SENSEX SHARES, 18 SHARES ROSE AND REMAINING SHARES DECLINED. SHARES OF ITC HAD HIT RECORD HIGH ON 19 OCTOBER 2012 AFTER THE COMPANY ANNOUNCED STRONG
Q2 RESULTS DURING TRADING HOURS ON THAT DAY. THE STOCK HAD HIT RECORD HIGH OF RS 299.20 IN
INTRADAY TRADE ON 19 OCTOBER 2012. ITC'S NET PROFIT JUMPED 21.27% TO RS 1836.42 CRORE ON
18.65% GROWTH IN INCOME FROM OPERATIONS TO RS 7226.58 CRORE IN Q2 SEPTEMBER 2012 OVER Q2
SEPTEMBER 2011.INDIA'S SECOND LARGEST PRIVATE SECTOR BANK BY NET PROFIT HDFC BANK ROSE
4.21% TO RS 669.50. THE STOCK HIT A RECORD HIGH OF RS 672.50 IN INTRADAY TRADE ON FRIDAY, 23
NOVEMBER 2012. HDFC BANK'S NET PROFIT JUMPED 30.06% TO RS 1559.98 CRORE ON 24.47%
GROWTH IN TOTAL INCOME TO RS 9869.8 CRORE IN Q2 SEPTEMBER 2012 OVER Q2 SEPTEMBER 2011.
HDFC BANK ANNOUNCED THE SECOND QUARTER RESULTS ON 12 OCTOBER 2012.
.
EXPERT OPINION
NIFTY BANK NIFTY
Nifty looks Consolidate Bank Nifty looks Consolidate
Strategy: Buy on dips Strategy: Buy on dips
Support:5573 Support: 11323
Resistance: 5675 Resistance: 11635
NIFTY WEELY PIVOTS
PIVOTS R4 R3 R2 R1 PP S1 S2 S3 S4
NIFTY 5921 5819 5717 5675 5615 5573 5513 5411 5309
http://www.epicresearch.co 09752199966
NIFTY WEEKLY CHART
WEEKLY BANK NIFTY CHART
.
GAINERS AND LOOSERS
WEEKLY NIFTY GAINERS
SCRIPS RATE VOL. (000) PR.
CLOSE
NET
CHANGE
% CHANGE
Mahindra & Mahindra
954.05 790.35 894.45 59.6 6.66
HCL Tech. 636.45 991.3 607.75 28.7 4.72
ITC 286.6 5472.29 274.65 11.95 4.35 HDFC Bank 669.75 3025.71 642.25 27.5 4.28
Sun Pharma Inds.
705.3 716.57 679 26.3 3.87
WEEKLY NIFTY LOOSERS
SCRIPS RATE VOL.
(000)
PR. CLOSE NET
CHANGE
% CHANGE
Ranbaxy Labs. 496.35 417.03 521.6 -25.25 -4.84
NTPC 159.4 1346.34 166.4 -7 -4.21
Lupin 560.2 697.86 576.6 -16.4 -2.84
ONGC 251.2 4009.47 257.9 -6.7 -2.6 BHEL 224.7 1967.68 230.3 -5.6 -2.43
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.